Convulex 150 Capsule Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

convulex 150 capsule

axapharm ag - acido valproicum - capsule - acido valproicum 150 mg, excipiens pro capsula. - antiepilepticum - synthetika

Convulex 300 Capsule Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

convulex 300 capsule

axapharm ag - acido valproicum - capsule - acido valproicum 300 mg, excipiens pro capsula. - antiepilepticum - synthetika

Convulex 500 Capsule Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

convulex 500 capsule

axapharm ag - acido valproicum - capsule - acido valproicum 500 mg, excipiens pro capsula. - antiepilepticum - synthetika

Convulex Sirup Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

convulex sirup

axapharm ag - natrii valproas - sirup - natrii valproas 50 mg, sono, saccharinum natricum, natrii cyclamas, conserv.: propylis parahydroxybenzoas, e 218, excipiens ad una soluzione per 1 ml. - antiepilepticum - synthetika

Sandimmun Neoral 25 mg Capsule Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandimmun neoral 25 mg capsule

novartis pharma schweiz ag - ciclosporinum - capsule - ciclosporinum 25 mg, ethanolum anhydricum 25 mg, propylenglycolum 25 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 101.25 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 21.42 mg, gelatina, e 172 (nigrum), drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Sandimmun Neoral 50 mg Capsule Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandimmun neoral 50 mg capsule

novartis pharma schweiz ag - ciclosporinum - capsule - ciclosporinum 50 mg, ethanolum anhydricum 50 mg, propylenglycolum 50 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 202.5 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 40.36 mg, gelatina, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Sandimmun Neoral 100 mg Capsule Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandimmun neoral 100 mg capsule

novartis pharma schweiz ag - ciclosporinum - capsule - ciclosporinum 100 mg, ethanolum anhydricum 100 mg, propylenglycolum 100 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 405 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 48.31 mg, gelatina, e 172, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Sandimmun Neoral 10 mg Capsule Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandimmun neoral 10 mg capsule

novartis pharma schweiz ag - ciclosporinum - capsule - ciclosporinum 10 mg, ethanolum anhydricum 10 mg, propylenglycolum 10 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 40.5 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum) 6.9 mg, propylenglycolum 10.8 mg, gelatina, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

Sandimmun Neoral Trinklösung Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandimmun neoral trinklösung

novartis pharma schweiz ag - ciclosporinum - trinklösung - ciclosporinum 100 mg, ethanolum anhydricum 94.7 mg, propylenglycolum 94.7 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 383.7 mg, e 307, ad solutionem pro 1 ml corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

L-Polamidon 5 mg/mL Soluzione orale Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

l-polamidon 5 mg/ml soluzione orale

sandoz pharmaceuticals ag - levomethadoni hydrochloridum - soluzione orale - levomethadoni hydrochloridum 5 mg corresp. levomethadonum 4.47 mg, betaini hydrochloridum, e 218 1.5 mg, glycerolum (85 per centum), aqua purificata, ad solutionem pro 1 ml. - analgesico - synthetika